Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20–30% of patients will relapse despite appropriate locoregional and systemic therapies. A better knowledge of this disease is improving our ability to select the most appropriate therapy for each patient with a recent diagnosis of an early stage breast cancer, minimizing unnecessary toxicities and improving long-term efficacy.
CITATION STYLE
Ayala de la Peña, F., Andrés, R., Garcia-Sáenz, J. A., Manso, L., Margelí, M., Dalmau, E., … Ciruelos, E. (2019). SEOM clinical guidelines in early stage breast cancer (2018). Clinical and Translational Oncology, 21(1), 18–30. https://doi.org/10.1007/s12094-018-1973-6
Mendeley helps you to discover research relevant for your work.